Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has expanded...

Related Keywords

Switzerland ,Ukraine ,United States ,Israel ,Russia ,American ,Russian ,Sari Fishman ,Fite Vp Business Development Dr ,Fite Biopharma Ltd ,Drug Administration ,Can Fite Biopharma ,Switzerland Based Ewopharma ,Central Eastern European ,Central Eastern Europe ,Fite Biopharma ,Orphan Drug Designation ,Fast Track Designation ,Annual Report ,Markets ,